Skip to content
Lumen Bioscience awarded $3.6 million by U.S. Army to advance low-cost, scalable preventative for antibiotic-resistant infections
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.OkI do not consent
Toggle navigation